Trial Profile

A first in man phase I trial of NPM-139 for Obesity

Status: Planning

Phase of Trial: Phase I

Latest Information Update: 24 Oct 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

24 Oct 2025 New trial record
04 Sep 2025 According to a Vivani Medical media release, the company plans to initiate a Phase 1 clinical study in the NPM-139 semaglutide implant program in the first half of 2026, pending regulatory clearance.
13 Aug 2025 According to a Vivani Medical media release, the company anticipates providing a more detailed update on the NPM-139 program later this year, including the proposed design of the clinical program and the dose-ranging weight maintenance study outcomes.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com